JE Greensher, J Louie, JD Fish - Pediatric Blood & Cancer, 2018 - Wiley Online Library
Opsoclonus myoclonus ataxia syndrome (OMAS) can be refractory to standard therapies and devastating. Alternative treatments are imperative. A 14‐month‐old male diagnosed …
Цель исследования изучение и анализ особенностей психического развития детей с опсоклонус-миоклонус-синдромом (ОМС) в сопоставлении с числом обострений …
X Ding, W Han, J Wang, W Yang, XF Chang… - Pediatric …, 2019 - nature.com
Background Opsoclonus-myoclonus syndrome (OMS) is a rare neurological disorder, usually accompanied by neuroblastoma (NB). There is no targeted treatment and animal …
TI Stetsenko, HM Fedushka… - Modern Pediatrics …, 2024 - mpu.med-expert.com.ua
Opsoclonus-myoclonus-ataxia syndrome (OMAS) is an autoimmune rare disease of the central nervous system with lesion of the cerebellum and its ligaments. Purpose-to present a …
Синдром опсоклонус-міоклонус (СОМ), або енцефалопатія Кінсбурна–унікальне й рідкісне неврологічне захворювання, що викликає труднощі в діагностиці, тактиці …
Modern principles of diagnosis and treatment of Kinsbourne encephalopathy (a clinical case) | Zaporozhye мedical journal Skip to main content Skip to main navigation menu Skip to site footer …
Objective: to investigate and analyze the specific features of mental development in children with opsoclonus-myoclonus syndrome (OMS) in relation to the number of exacerbations …
CC Sabbaga, LA Antunes, C Talini… - Ann Clin Case Rep … - anncaserep.com
The opsoclonus-myoclonus-ataxia syndrome (OMAS) also known as Kinsbourne syndrome can occur as a single neurological event in children with paraneoplastic syndrome in a …